News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152 Results
Type
Article (2)
Press Release (150)
Section
Business (61)
Deals (11)
Drug Development (9)
FDA (1)
News (78)
Policy (3)
Tag
Alliances (19)
Approvals (1)
Artificial intelligence (1)
Cancer (1)
Clinical research (2)
COVID-19 (2)
Diabetes (1)
Diagnostics (1)
Earnings (30)
Events (27)
FDA (1)
GLP-1 (1)
Government (1)
Healthcare (16)
Infectious disease (2)
IPO (8)
Mergers & acquisitions (4)
Metabolic disorders (1)
People (13)
Phase I (2)
Phase II (2)
Phase III (1)
Preclinical (8)
Regulatory (2)
United States (2)
Date
Today (1)
Last 7 days (2)
Last 30 days (2)
Last 365 days (22)
2025 (2)
2024 (20)
2023 (24)
2022 (27)
2021 (34)
2020 (34)
2019 (3)
2018 (4)
2017 (4)
Location
Asia (2)
Canada (17)
China (1)
Europe (6)
Texas (2)
152 Results for "immunoprecise".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
January 17, 2025
·
4 min read
Business
ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer
ImmunoPrecise Antibodies Ltd. is pleased to announce the appointment of Kristin Taylor as Chief Financial Officer, effective immediately.
June 27, 2024
·
3 min read
Press Releases
ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases
December 23, 2024
·
4 min read
Press Releases
IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment
January 22, 2025
·
6 min read
Press Releases
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
November 5, 2024
·
5 min read
Press Releases
ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
October 2, 2024
·
7 min read
Press Releases
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025
December 10, 2024
·
11 min read
News
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
October 21, 2024
·
1 min read
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.
June 12, 2024
·
5 min read
Press Releases
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
September 27, 2024
·
9 min read
1 of 16
Next
